Precose (acarbose) decreases the risk of hypertension and heart disease in PRE-diabetes patients
New evidence suggests that Precose (acarbose) decreases the risk of hypertension and heart disease in PRE-diabetes patients.
Many of these patients develop type 2 diabetes...and can have up to a 10 times higher risk of heart disease-related death.
Pre-diabetes patients who take Precose over 3 years have a lower risk of developing diabetes...hypertension...and heart disease.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote